Study with methyl salicylate 30 g to evaluate the safety and effectiveness of methyl salicylate 30 g and 1 g benzocaine ointment as an adjunct in the treatment of knee osteoarthritis and musculoskeletal pain.
Not Applicable
- Conditions
- -M255M255
- Registration Number
- PER-036-13
- Lead Sponsor
- ABORATORIOS FARMASUR S.A.C.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Patients over 18 years
oWith clinical diagnosis (contained in medical records) of:
Knee pain and osteoarthritis product
musculoskeletal pain or mechanical type (low back pain, neck pain, knee pain)
They have given their informed consent.
Exclusion Criteria
Be excluded:
Patients with any history of adverse reactions of components forming part of the treatment.
Patients with lesions / wounds or conditions that impair the integrity of the skin in the areas where the product is applied.
Women pregnant or breastfeeding are providing.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method